Public-domain · open source
OpenJurist

covered countermeasure

Defined in 3 places of the United States Code.

The term “covered countermeasure” has the meaning given such term in section 247d–6d of this title.

Source

The term "covered countermeasure" means—

(A) a qualified pandemic or epidemic product (as defined in paragraph (7));

(B) a security countermeasure (as defined in section 247d–6b(c)(1)(B) of this title);

(C) a drug (as such term is defined in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1)), biological product (as such term is defined by section 262(i) of this title), or device (as such term is defined by section 201(h) of the Federal Food, Drug and Cosmetic Act (21 U.S.C. 321(h)) that is authorized for emergency use in accordance with section 564, 564A, or 564B of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 360bbb–3, 360bbb–3a, 360bbb–3b]; or

(D) a respiratory protective device that is approved by the National Institute for Occupational Safety and Health under part 84 of title 42, Code of Federal Regulations (or any successor regulations), and that the Secretary determines to be a priority for use during a public health emergency declared under section 247d of this title.

Source

  • 2020–present42 U.S.C. § 247DThe Public Health and Welfare · Targeted liability protections for pandemic and epidemic products and security countermeasures · in this section

The term “covered countermeasure” means—

(A) a qualified pandemic or epidemic product (as defined in paragraph (7));

(B) a security countermeasure (as defined in section 247d–6b(c)(1)(B) of this title); or

(C) a drug (as such term is defined in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1)), biological product (as such term is defined by section 262(i) of this title), or device (as such term is defined by section 201(h) of the Federal Food, Drug and Cosmetic Act (21 U.S.C. 321(h)) that is authorized for emergency use in accordance with section 564, 564A, or 564B of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 360bbb–3, 360bbb–3a, 360bbb–3b].

Source

  • 2013–202042 U.S.C. § 247DThe Public Health and Welfare · Targeted liability protections for pandemic and epidemic products and security countermeasures · in this section

The term “covered countermeasure” means—

(A) a qualified pandemic or epidemic product (as defined in paragraph (7));

(B) a security countermeasure (as defined in section 247d–6b(c)(1)(B) of this title); or

(C) a drug (as such term is defined in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1)), biological product (as such term is defined by section 262(i) of this title), or device (as such term is defined by section 201(h) of the Federal Food, Drug and Cosmetic Act (21 U.S.C. 321(h)) that is authorized for emergency use in accordance with section 564 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 360bbb–3].

Source

  • 2005–201342 U.S.C. § 247DThe Public Health and Welfare · Targeted liability protections for pandemic and epidemic products and security countermeasures · in this section

The term “covered countermeasure” means a covered countermeasure as specified in a Declaration made pursuant to section 233(p) of this title.

Source

The term “covered countermeasure” or “covered countermeasure against smallpox”, means a substance that is—

(i) (I) used to prevent or treat smallpox (including the vaccinia or another vaccine); or

(II) used to control or treat the adverse effects of vaccinia inoculation or of administration of another covered countermeasure; and

(ii) specified in a declaration under paragraph (2).

Source

  • 2003–present42 U.S.C. § 233The Public Health and Welfare · Civil actions or proceedings against commissioned officers or employees · under this section

The term “covered countermeasure” or “covered countermeasure against smallpox”, means a substance that is—

(i) (I) used to prevent or treat smallpox (including the vaccinia or another vaccine); or

(II) vaccinia immune globulin used to control or treat the adverse effects of vaccinia inoculation; and

(ii) specified in a declaration under paragraph (2).

Source

  • 2002–200342 U.S.C. § 233The Public Health and Welfare · Civil actions or proceedings against commissioned officers or employees · under this section